Search stocks

Find any stock by ticker or company name

Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

Follow us

Instagram
Telegram
LinkedIn

All rights reserved.

Privacy Policy Terms of Conditions

Home
Watchlist
Markets
Calendar
Screener
News
About

TPST - Tempest Therapeutics, Inc. Financial... | Finranks

Home

/

TPST

T

Tempest Therapeutics, Inc. (TPST)

NCM – Real Time Price. Currency in USD

1.21

+0.03 (2.58%)

Market open: Aug 12, 2026, 10:47 AM EDT

1.17

-0.01 (-0.84%)

Previous after-hours: Aug 11, 2026, 7:42 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Total Assets

Total Liabilities

Stockholders Equity

Total Debt

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

0

0

0

0

Cost of goods sold

-266K

-389K

-381K

-2M

Gross Profit

-266K

-389K

-381K

-2M

Operating expenses (excl. COGS)

-26M

-42M

-29M

-33M

Operating Income

-27M

-42M

-29M

-35M

Non-operating income, total

313K

183K

-334K

-1M

Pretax income

-26M

-42M

-29M

-36M

Equity in earnings

0

0

0

0

Taxes

0

0

0

0

Non-controlling/minority interest

0

0

0

0

After tax other income/expense

0

0

0

0

Net income before discontinued operations

-26M

-42M

-29M

-36M

Discontinued operations

0

0

0

0

Net income

-26M

-42M

-29M

-36M

Dilution adjustment

0

0

0

0

Preferred dividends

0

0

0

0

Name

2025

2024

2023

2022

Total assets

19M-56.5%

44M-14.7%

52M+12.0%

46M

Total current assets

8M

31M

40M

33M

Total non-current assets

11M

13M

11M

13M

Total liabilities

12M-49.9%

25M+0.3%

25M-11.2%

28M

Total current liabilities

3M

14M

9M

7M

Total non-current liabilities

9M

11M

15M

21M

Total equity

7M

19M

27M

18M

Total liabilities & shareholders' equities

19M

44M

52M

46M

Total debt

8M-47.0%

15M-25.6%

21M-6.6%

22M

Name

2025

2024

2023

2022

Cash from operating activities

-27M

-33M

-27M

-31M

Cash from investing activities

0

-435K

-170K

-562K

Cash from financing activities

4M

25M

36M

11M

Free cash flow

-27M+19.8%

-33M-21.6%

-28M+13.0%

-32M